Stereoselective synthesis and antiviral activity of (1E,2Z,3E)-1- (piperidin-1-yl)-1-(arylhydrazono)-2-[(benzoyl/benzothiazol-2-oyl)hydrazono] -4-(aryl1)but-3-enes

Archiv der Pharmazie

Volumn 343, Issue 3, 2010, Pages 152-159

  Abdel Aziza, Hatem A ^a,b   Abdel Wahab, Bakr F ^b   Badria, Farid A ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

Author keywords

Antiviral activity; Benzothiazole; HSV 1; Hydrazones; X ray crystallography

Indexed keywords

(1,2,3) 1 (PIPERIDIN 1 YL) 1 (4 CHLOROPHENYLHYDRAZONO) 2 [(BENZOTHIAZOL 2 OYL)HYDRAZONO] 4 (PHENYL)BUT 3 ENE; (1,2,3) 1 (PIPERIDIN 1 YL) 1 (4 NITROPHENYL HYDRAZONO) 2 [(BENZOTHIAZOL 2 OYL)HYDRAZONO] 4 (PHENYL)BUT 3 ENE; (1,2,3) 1 (PIPERIDIN 1 YL) 1 (4 TOLYLHYDRAZONO) 2 [(BENZOYL)HYDRAZONO] 4 (PHENYL)BUT 3 ENE; (1,2,3) 1 (PIPERIDIN 1 YL) 1 (4 TOLYLHYDRAZONO) 2 [(BENZOYL)HYDRAZONO] 4 (THEIN 2 YL)BUT 3 ENE; (1,2,3) 1 (PIPERIDIN 1 YL) 1 (ARYLHYDRAZONO) 2 [(BENZOYL/BENZOTHIAZOL 2 OYL)HYDRAZONO] 4 (ARYL 1)BUT 3 ENE DERIVATIVE; (1,2,3) 1 (PIPERIDIN 1 YL) 1 (PHENYLHYDRAZONO) 2 [(BENZOTHIAZOL 2 OYL)HYDRAZONO] 4 (PHENYL) BUT 3 ENE; (1,2,3) 1 (PIPERIDIN 1 YL) 1 (PHENYLHYDRAZONO) 2 [(BENZOYL)HYDRAZONO] 4 (4 METHOXYPHENYL) BUT 3 ENE; (1,2,3) 1 (PIPERIDIN 1 YL) 1 (PHENYLHYDRAZONO) 2 [(BENZOYL)HYDRAZONO] 4 (PHENYL)BUT-3-ENE; ANTIVIRUS AGENT; APHIDICOLIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY; X RAY ANALYSIS;

ANTIVIRAL AGENTS; APHIDICOLIN; BENZOTHIAZOLES; HERPESVIRUS 1, HUMAN; HYDRAZONES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77949403640     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200900195     Document Type: Article

References (46)

1. R. Gupta, T. Warren, A. Wald, Lancet 2007, 370, 2127-2137.
2. D. W. Kimberlin, Semin. Perinatol. 2007, 31, 19-25.
3. D. J. McGeoch, F. J. Rixon, A. J. Davison, Virus Res. 2006, 117, 90-104.
4. F. B. Dickerson, J. J. Boronow, C. Stallings, A. E. Origoni, et al., Biol. Psychiatry 2004, 55, 588-593.
5. M. Soumyajit, E. N. Yasser, P. Kunal, J. Ritesh, et al., J. Ocul. Pharmacol. Ther. 2005, 21, 463-474.
6. M. A. Wozniak, A. P. Mee, R. F. Itzhaki, J. Pathol. 2009, 217, 131-138.
7. R. F. Itzhaki, W. R. Lin, D. Shang, G. K. Wilcock, et al., Lancet 1997, 349, 241-244.
8. C. B. Dobson, R. F. Itzhaki, Neurobiol. Aging 1999, 20, 457-465.
9. M. T. Abdel-Aal, W. A. El-Sayed, E. H. El-Ashry, Arch. Pharm. Chem. Life Sci. 2006, 339, 656-663.
10. W. G. Brouwer, E. M. Osika, US Patent 1999, 5914351.
11. R. F. Abdulla, US Patent 1987, 4670437.
12. S. Akerfeldt, J. Med. Chem. 1970, 13, 1012-1013.
13. T. Wang, J. F. Kadow, N. A. Meanwell, WO Patent 2005, 120508.
14. L. Racane, V. Tralic-Kulenovic, L. Fiser-Jakic, D. W. Boykin, G. Karminski-Zamola, Heterocycles 2001, 55, 2085-2098.
15. M. A. El-Sherbeny, Arzneim.-Forsch. 2000, 50, 848-853.
16. F. A. Badria, A. Mohamed, R. M. Botros, T. M. Galal, M. A. Mohamed, Biosci. Biotechnol. Res. Asia 2003, 1, 1-10.
17. H. I. El-Subbagh, S. M. Abu-Zaid, M. A. Mahran, F. A. Badria, M. Al-Obaid, J. Med. Chem. 2000, 43, 2915-2921.
18. E. R. El-Bendary, F. A. Badria, Arch. Pharm. 2000, 333, 99-103.
19. M. A. El-Sherbeny, F. A. Badria, S. A. Kheira, Med. Chem. Res. 1996, 6, 28-39.
20. M. A. El-Sherbeny, M. B. El-Ashmawy, H. I. El-Subbagh, A. A. El-Emam, F. A. Badria, Eur. J. Med. Chem. 1995, 30, 445-449.
21. H. A. Abdel-Aziz, A. A. I. Mekawey, Eur. J. Med. Chem. 2009, 44, 4985-4997.
22. H. A. Abdel-Aziz, A. A. I. Mekawey, K. M. Dawood, Eur. J. Med. Chem. 2009, 44, 3637-3644.
23. H. A. Abdel-Aziz, A. M. Gamal-Eldeen, N. A. Hamdy, I. M. I. Fakhr, Arch. Pharm. Chem. Life Sci. 2009, 342, 230-237.
24. H. A. Abdel-Aziz, B. F. Abdel-Wahab, M. A. M. S. El-Sharief, M. M. Abdulla, Monatsh. Chem. 2009, 140, 341-347.
25. B. F. Abdel-Wahab, H. A. Abdel-Aziz, E. M. Ahmed, Eur. J. Med. Chem. 2009, 44, 2632-2635.
26. B. F. Abdel-Wahab, H. A. Abdel-Aziz, E. M. Ahmed, Monatsh. Chem. 2009, 140, 601-605.
27. B. F. Abdel-Wahab, H. A. Abdel-Aziz, E. M. Ahmed, Arch. Pharm. Chem. Life Sci. 2008, 341, 734-739.
28. M. Artico, R. Silvestri, S. Massa, A. G. Loi, et al., J. Med. Chem. 1996, 39, 522-530.
29. C. E. Stephens, T. M. Felder, J. W. Sowell, G. S. Andrei, et al., Bioorg. Med. Chem. 2001, 9, 1123-1132.
30. R. Silvestri, M. Artico, G. de Martino, E. Novellino, et al., Bioorg. Med. Chem. 2000, 8, 2305-2309.
31. G. Stamatiou, G. B. Foscolos, G. Fytas, A. Kolocouris, et al., Bioorg. Med. Chem. 2003, 11, 5485-5492.
32. Y. Ueda, T. P. Connolly, J. F. Kadow, N. A. Meanwell, et al., WO Patent 2005, 090367.
33. W. M. Kazmierski, C. Aquino, B. A. Chauder, F. Deanda, et al., J. Med. Chem. 2008, 51, 6538-6546.
34. G. D. Diana, US Patent 1994, 5364865.
35. S. Dong-Ming, S. Min, A. W. Christopher, S. Shrenik, et al., Bioorg. Med. Chem. 2004, 14, 941-945.
36. A. O. Robert, E. S. David, A. K. Laurice, M. P. Susan, et al., J. Virology 1996, 3698-3705.
37. I. Shinichi, N. Youichi, I. Takashi, H. Taeko, et al., Bioorg. Med. Chem. 2005, 13, 397-416.
38. K. Shankaran, L. D. Karla, K. S. Shrenik, G. C. Charles, et al., Bioorg. Med. Chem. Lett. 2004, 14, 3589-3593.
39. T. Wang, Y. Han, J. F. Kadow, Z. Zhang, N. A. Meanwell, WO Patent 2007, 146550.
40. W. Tao, F. K. John, Z. Zhongxing, Y. Zhiwei, et al., US Patent 2007, 0249579.
41. M. Abou-Karam, W. T. Shier, J. Nat. Prod. 1990, 53, 340-345.
42. C. D. Hufford, F. A. Badria, M. Abou-Karam, W. T. Shier, R. D. Rogers, J. Nat. Prod. 1991, 54, 1543-1552.
43. A. R. Maarouf, F. A. Badria, Malays. J. Pharm. Sci. 2005, 21, 42-58.
44. E. Campaigne, R. L. Thompson, J. E. Van Werths, J. Med. Chem. 1959, 1, 577-599.
45. W. Dieckmann, O. Platz, Ber. Dtsch. Chem. Ges. 1906, 38, 2989-2995.
46. A. Altomare, G. Cascarano, C. Giacovazzo, A. Guagliardi, et al., J. Appl. Cryst. 1994, 27, 435-436.